Safety of Exposure to Natalizumab During Pregnancy

Clinical trial NCT05209815 · COMPLETED

Trial details

NCT number: NCT05209815
Sponsor: University Hospital, Bordeaux
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2022-06-20
Primary completion: 2023-12-22
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.